Impact of renin–angiotensin system inhibitors on the clinical outcomes of nivolumab therapy in metastatic non–small cell lung cancer

In this multicenter real-world study of patients with mNSCLC receiving second-line nivolumab, concomitant use of RASIs was associated with PFS and OS. The integration of RAS blockade into immunotherapy regimens could represent a promising strategy to enhance treatment efficacy.

Authors

Institutions

Publication Details

Journal
Expert Review of Anticancer Therapy
Published
2026-01-09
DOI
https://doi.org/10.1080/14737140.2026.2615853
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of renin–angiotensin system inhibitors on the clinical outcomes of nivolumab therapy in metastatic non–small cell lung cancer

Mehmet Mutlu Kıdı, M. Erman, M. Polat Inanc, S. Kılıçkap et al.
Expert Review of Anticancer Therapy
Cancer Immunotherapy and Biomarkers
article

Impact of renin–angiotensin system inhibitors on the clinical outcomes of nivolumab therapy in metastatic non–small cell lung cancer

Mehmet Mutlu Kıdı, M. Erman, M. Polat Inanc, S. Kılıçkap, Anıl Karakayalı, Teoman Şakalar, Sedat Yıldırım, Latif Karahan, muslih urun, Pervin Can Şancı, Cengiz Akosman, Hayati Arvas, Gözde Ağdaş, Sedat Biter, Erkam Kocaaslan, Deniz Can Güven, Mustafa Ersoy, Sedat Yıldız, Metin Özkan, Erdem Kolemen, Nargiz Majidova, Emel Mutlu Ozkan, Havva Yesıl Cınkır, Hacer Demir, Berrak Mermıt Ercek, Aslihan Ezgi Apaydın Rollas, Ibrahim Karadağ, Ezgi Turkoğlu, Tolga Kosecı, Umut Kefelı, Ayse Nuransoy Cengiz, Duygu Bayır, Elif Sahın, Muhammet Cengız, Devrim Cabuk
article en

Abstract

In this multicenter real-world study of patients with mNSCLC receiving second-line nivolumab, concomitant use of RASIs was associated with PFS and OS. The integration of RAS blockade into immunotherapy regimens could represent a promising strategy to enhance treatment efficacy.

Expert Review of Anticancer Therapy
Van Yüzüncü Yıl Üniversitesi (TR), Dicle University (TR), Heidelberg University (DE), Milpark Hospital (ZA), University Hospital Heidelberg (DE), Cork University Hospital (IE), Kütahya Dumlupınar Üniversitesi (TR), Dr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi (TR), Istinye University (TR), City Hospital (GB), Universidad CES (CO), Afyonkarahisar Sağlık Bilimleri Üniversitesi, Maltepe University (TR), Eskişehir Osmangazi University (TR), Kocaeli Üniversitesi (TR), Cukurova University (TR), Gaziantep University (TR), Hacettepe University (TR), Marmara University (TR), Erciyes University (TR)
Good health and well-being
Openalex Percentile: Top 93%
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.